Rchr
J-GLOBAL ID:201901018415539683   Update date: Mar. 22, 2024

masato mima

ミマ マサト | masato mima
Research field  (1): Otorhinolaryngology
Research theme for competitive and other funds  (3):
  • 2022 - 2025 Stratification and elucidation of therapeutic targets based on transcriptional regulation abnormalities in HPV-related oropharyngeal cancer
  • 2021 - 2024 Cell free RNA methylation genome-wide analysis in head and neck cancer
  • 2020 - 2023 HPV関連頭頸部扁平上皮癌のクロマチン構造解析による発癌分子機構の解明
Papers (41):
  • Harue Mizokami, Atsushi Okabe, Ruchi Choudhary, Masato Mima, Kenta Saeda, Masaki Fukuyo, Bahityar Rahmutulla, Motoaki Seki, Boon-Cher Goh, Satoru Kondo, et al. Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma. eBioMedicine. 2024. 102. 105057-105057
  • Masato Mima, Atsushi Okabe, Takayuki Hoshii, Takuya Nakagawa, Tomoya Kurokawa, Satoru Kondo, Harue Mizokami, Masaki Fukuyo, Ryoji Fujiki, Bahityar Rahmutulla, et al. Tumorigenic activation around HPV integrated sites in head and neck squamous cell carcinoma. International journal of cancer. 2023. 152. 9. 1847-1862
  • Satoru Kondo, Atsushi Okabe, Takuya Nakagawa, Keisuke Matsusaka, Masaki Fukuyo, Bahityar Rahmutulla, Hirotomo Dochi, Harue Mizokami, Yuki Kitagawa, Tomoya Kurokawa, et al. Repression of DERL3 via DNA methylation by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2022. 166598-166598
  • 美馬 勝人, 岡部 篤史, 中川 拓也, 黒川 友哉, 近藤 悟, 溝上 晴恵, 福世 真樹, 繩井 バハテヤリラヒムトラ, 星居 孝之, 三澤 清, et al. HPV挿入部位周辺のエピジェネティックな活性化による頭頸部扁平上皮癌発癌機構(Epigenetic activation of regions surrounding HPV integrated sites contributes to tumorigenesis of HNSCC). 日本癌学会総会記事. 2022. 81回. P-1293
  • 美馬 勝人, 溝上 晴恵, 中川 拓也, 黒川 友哉, 近藤 悟, 三澤 清. HPV関連頭頸部扁平上皮癌に対する3次元クロマチン構造解析. 日本耳鼻咽喉科頭頸部外科学会会報. 2022. 125. 4. 749-749
more...
MISC (19):
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page